Network Pharmacology-Based Characterization of Mecasin (KCHO-1) as a Multi-Target Modulator of Neuroinflammatory Pathways in Alzheimer’s Disease
Nutrients · 2025
DOI: 10.3390/nu18010008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Hyein Jo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Global Rare Disease Network, Professional Graduate School of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Network Pharmacology, Neuroinflammatory Diseases, Phytochemicals. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wonkwang University.
Themen: Demenz
Abstract (Originalsprache)
Background/Objectives: Mecasin (KCHO-1) is a standardized multi-herb formulation containing diverse bioactive compounds predicted to engage multiple molecular targets. This study applied an integrative network pharmacology approach to explore how Mecasin may interact with Alzheimer’s disease (AD)-related molecular networks.
Methods
Bioactive constituents from 9 herbs were screened through OASIS and PubChem, and their predicted targets were cross-referenced with 8886 AD-associated genes from GeneCards. Overlapping genes were analyzed using protein–protein interaction mapping, Gene Ontology, and KEGG to identify potential Mecasin–AD core nodes and pathways. Co-expression, co-regulation, and molecular docking analyses were performed to further characterize mechanistic relevance.
Results
Network integration identified 6 core genes—AKT1, STAT3, IL6, TNF, EGFR, and IL1B—positioned within signaling pathways related to neuronal survival, inflammatory regulation, and cellular stress responses, including FoxO, JAK–STAT, MAPK, and TNF pathways. Molecular docking suggested that several Mecasin compounds may interact with targets such as AKT1 and TNF.
Conclusions
These in silico findings indicate that Mecasin, a multi-component formulation containing numerous phytochemicals that generate broad compound–target associations, may interface with interconnected neuroimmune pathways relevant to AD. While exploratory, the results highlight potential multi-target mechanisms that merit further investigation and provide a systems-level framework to inform future experimental validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Global Rare Disease Network, Professional Graduate School of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea.
- Department of Pharmacology, School of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea.
- Research Center of Traditional Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea.
ORCID-Profile: Joonyoung Shin, Sungchul Kim
Förderung
- Wonkwang University
Zitieren
APA
Jo, H., Shin, J., Lee, H., Bae, G. S., & Kim, S. (2025). Network Pharmacology-Based Characterization of Mecasin (KCHO-1) as a Multi-Target Modulator of Neuroinflammatory Pathways in Alzheimer’s Disease. Nutrients. https://doi.org/10.3390/nu18010008
Vancouver
Jo H, Shin J, Lee H, Bae GS, Kim S. Network Pharmacology-Based Characterization of Mecasin (KCHO-1) as a Multi-Target Modulator of Neuroinflammatory Pathways in Alzheimer’s Disease. Nutrients. 2025. doi:10.3390/nu18010008
BibTeX
@article{Jo2025,
author = {Jo, Hyein and Shin, Joonyoung and Lee, Hyorin and Bae, Gi-Sang and Kim, Sungchul},
title = {Network Pharmacology-Based Characterization of Mecasin (KCHO-1) as a Multi-Target Modulator of Neuroinflammatory Pathways in Alzheimer’s Disease},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu18010008}
}
EUVIMED